Literature DB >> 15337523

Interleukin-2 (IL-2) receptor-betagamma signalling is activated by c-Kit in the absence of IL-2, or by exogenous IL-2 via JAK3/STAT5 in human papillomavirus-associated cervical cancer.

Leticia Rocha-Zavaleta1, Carlos Huitron, Julio R Cacéres-Cortés, José A Alvarado-Moreno, Arturo Valle-Mendiola, Isabel Soto-Cruz, Benny Weiss-Steider, Rosalva Rangel-Corona.   

Abstract

Activation of the interleukin-2 receptor (IL-2R) induces signalling cascades promoting T cell proliferation. However, signal transduction pathways triggered in IL-2R-expressing solid tumours are unknown. This report shows that human papillomavirus (HPV)-associated cervical cancer cells express an IL-2R composed of beta and gamma chains (IL-2Rbetagamma), and that IL-2-mediated activation increases the phosphorylation of JAK3 and STAT5, stimulating cell proliferation. Interestingly, endogenous IL-2 is not produced by these cells, suggesting the activation of IL-2Rbetagamma by an alternative mechanism. Accordingly, we found that Stem Cell Factor (SCF)-activated c-Kit induces phosphorylation of the IL-2Rbeta chain in the absence of IL-2. Moreover, inhibition of IL-2Rbeta phosphorylation by blocking c-Kit tyrosine kinase activity abolishes both, IL-2 and SCF-mediated proliferation. Thus, these results demonstrate that IL-2 triggers a JAK3/STAT5 cascade in HPV-associated cervical cancer cells expressing IL-2Rbetagamma, and that this receptor can be alternatively activated by SCF-activated c-Kit in the absence of IL-2.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15337523     DOI: 10.1016/j.cellsig.2004.03.011

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  9 in total

1.  Nitric-oxide synthase trafficking inducer is a pleiotropic regulator of endothelial cell function and signaling.

Authors:  Shreeta Chakraborty; Rupasri Ain
Journal:  J Biol Chem       Date:  2017-02-24       Impact factor: 5.157

2.  Characterization of transcription factor binding to human papillomavirus type 16 DNA during cellular differentiation.

Authors:  Andrew Carson; Saleem A Khan
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

3.  Investigation of molecular mechanisms underlying JAK/STAT signaling pathway in HPV-induced cervical carcinogenesis using 'omics' approach.

Authors:  Kulbhushan Thakur; Divya Janjua; Gauri Shishodia; Arun Chhokar; Nikita Aggarwal; Joni Yadav; Tanya Tripathi; Apoorva Chaudhary; Anna Senrung; Alok Chandra Bharti
Journal:  Med Oncol       Date:  2022-10-12       Impact factor: 3.738

4.  An association study of polymorphisms in JAK3 gene with lung cancer in the Korean population.

Authors:  Wonbeak Yoo; Hae-Yun Jung; Seungjoon Lim; Jae Sook Sung; Kyong Hwa Park; Jeong Seon Ryu; Sang Won Shin; Jun Suk Kim; Jae Hong Seo; Yeul Hong Kim
Journal:  Cancer Res Treat       Date:  2011-06-30       Impact factor: 4.679

5.  Effects of Di-(2-ethylhexyl) Phthalate on Lipid Metabolism by the JAK/STAT Pathway in Rats.

Authors:  Yiyang Jia; Te Liu; Liting Zhou; Jian Zhu; Juan Wu; Di Sun; Jin Xu; Qi Wang; Huaiji Chen; Feng Xu; Yuezhu Zhang; Tianrong Zhang; Hongbo Liu; Lin Ye
Journal:  Int J Environ Res Public Health       Date:  2016-11-04       Impact factor: 3.390

6.  Cervical Cancer Cells Express Markers Associated with Immunosurveillance.

Authors:  Adriana Gutiérrez-Hoya; Octavio Zerecero-Carreón; Arturo Valle-Mendiola; Martha Moreno-Lafont; Rubén López-Santiago; Benny Weiss-Steider; Isabel Soto-Cruz
Journal:  J Immunol Res       Date:  2019-05-06       Impact factor: 4.818

Review 7.  Pleiotropic Effects of IL-2 on Cancer: Its Role in Cervical Cancer.

Authors:  Arturo Valle-Mendiola; Adriana Gutiérrez-Hoya; María del Carmen Lagunas-Cruz; Benny Weiss-Steider; Isabel Soto-Cruz
Journal:  Mediators Inflamm       Date:  2016-05-12       Impact factor: 4.711

Review 8.  Cancer stem cells (CSCs), cervical CSCs and targeted therapies.

Authors:  Ruixia Huang; Einar K Rofstad
Journal:  Oncotarget       Date:  2017-05-23

9.  IL-2 Induces Transient Arrest in the G1 Phase to Protect Cervical Cancer Cells from Entering Apoptosis.

Authors:  María Del Carmen Lagunas-Cruz; Arturo Valle-Mendiola; Jonathan Trejo-Huerta; Leticia Rocha-Zavaleta; María de Lourdes Mora-García; Adriana Gutiérrez-Hoya; Benny Weiss-Steider; Isabel Soto-Cruz
Journal:  J Oncol       Date:  2019-09-26       Impact factor: 4.375

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.